Pfizer Wants Chinese Partners to License Local Therapies

shot by IP News Shots / 6:09 pm on 18 November, 2020

Pfizer Inc. has announced that it is on the lookout for partners among Chinese biotechnology firms that are in the arena of developing novel drugs. The announcement follows the price cut drive by Beijing which led to losses for the pharma company.

Read More at: https://www.bloomberg.com/news/articles/2020-11-17/pfizer-seeks-deals-with-chinese-biotechs-to-offset-lost-revenue

Industry: Pharmaceuticals | Type of IP: Deals - Licensing